PuraPharm Corporation Limited (HKG:1498)

PuraPharm Corporation Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.17	12.79	20.13	75.83	59.67
Short-Term Investments	19.73	24.1	22.85	15.53	36.39
Cash & Short-Term Investments	35.9	36.9	42.98	91.36	96.06
Cash Growth	-2.72%	-14.14%	-52.96%	-4.89%	-27.53%
Accounts Receivable	56.41	57.5	80.87	131.87	261.41
Other Receivables	5.24	7.09	8.77	8.5	2.25
Receivables	61.64	64.59	89.64	140.37	263.65
Inventory	99.19	123.56	175.6	190.81	199.8
Prepaid Expenses	21.84	14.25	10.19	26.69	23.56
Restricted Cash	0.01	0.01	27.1	31.18	25.38
Other Current Assets	8.51	29.14	4.08	5.58	2.41
Total Current Assets	227.09	268.44	349.57	486	610.86
Property, Plant & Equipment	352.72	355.39	396.91	431.08	461.02
Long-Term Investments	3.61	3.7	2.96	1.2	-
Goodwill	17.94	17.94	17.94	20.99	20.99
Other Intangible Assets	67	31.56	34.74	37.64	41.06
Long-Term Deferred Tax Assets	6.87	7.7	8.82	11.05	10.48
Other Long-Term Assets	18.53	30.99	33.03	28.54	61.45
Total Assets	693.76	715.73	843.96	1,016	1,206

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	85.23	132.21	146.38	137.91	140.68
Short-Term Debt	60.29	134.76	250.8	353.7	362.05
Current Portion of Long-Term Debt	208.02	115.79	53.22	56.44	45.62
Current Portion of Leases	15.81	13.63	17.97	18.51	13.24
Current Income Taxes Payable	3.52	7.71	2.07	1.44	3.58
Current Unearned Revenue	0.17	0.17	0.17	0.25	2.34
Other Current Liabilities	106.38	86.8	100.48	97.16	97.81
Total Current Liabilities	479.42	491.07	571.09	665.41	665.31
Long-Term Debt	55.51	89.16	81.09	48.68	92
Long-Term Leases	11.52	10.42	21.68	25.83	19.05
Long-Term Unearned Revenue	2.69	1.9	1.08	1.03	1.17
Long-Term Deferred Tax Liabilities	2.2	0.97	1.74	3.02	2.61
Other Long-Term Liabilities	11.96	11.02	14.04	14.25	24.16
Total Liabilities	563.27	604.53	690.73	758.21	804.31

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.15	306.82	306.82	306.82	306.04
Additional Paid-In Capital	280.69	221.57	221.57	221.57	221.19
Retained Earnings	-125.6	-394.13	-358.69	-252.63	-133.03
Comprehensive Income & Other	-28.76	-23.06	-16.47	-17.47	7.36
Shareholders' Equity	130.48	111.2	153.24	258.29	401.56
Total Liabilities & Equity	693.76	715.73	843.96	1,016	1,206

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	351.14	363.76	424.77	503.16	531.96
Net Cash (Debt)	-315.25	-326.86	-381.8	-411.8	-435.9
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.75	-0.83	-0.97	-1.04	-1.11
Filing Date Shares Outstanding	535.05	395.05	395.05	395.05	393.93
Total Common Shares Outstanding	535.05	395.05	395.05	395.05	393.93
Working Capital	-252.33	-222.63	-221.52	-179.41	-54.46
Book Value Per Share	0.24	0.28	0.39	0.65	1.02
Tangible Book Value	45.54	61.69	100.55	199.66	339.5
Tangible Book Value Per Share	0.09	0.16	0.25	0.51	0.86
Land	222.9	218.08	225.23	225.13	234.75
Machinery	207.16	197.51	204.33	203.97	203.05
Construction In Progress	70.59	68.99	69.18	71.28	77.66
Leasehold Improvements	27.86	29.76	15.7	16.51	24.31

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error